Table 1.

Characteristics and first course of treatment of Latino and non-Latino White men diagnosed with high-risk localized prostate cancer in California from 2010–2014.

	Non-Latino White N= 8636		Latino N= 2421		Total N= 11,057
	N	Column %	N	Column %	N
Treatment	6764	78.3%	1793	74.1%	8557
Definitive treatment
Radical prostatectomy	3127	36.2%	759	31.4%	3886
Radiation with ADT	2688	31.1%	752	31.1%	3440
Radiation without ADT	865	10.0%	266	11.0%	1131
Cryoablation	84	1.0%	16	0.7%	100
Non-Definitive Treatment	1166	13.5%	372	15.4%	1538
ADT monotherapy	982	11.4%	324	13.4%	1306
Other surgery	184	2.1%	48	2.0%	232
No treatment documented	706	8.2%	256	10.6%	962
Clinical T stage	4325	50.1%	1312	54.2%	5637
T1
T2	3209	37.2%	835	34.5%	4044
T3	1016	11.8%	249	10.3%	1265
T4	86	1.0%	25	1.0%	111
Biopsy Gleason score	604	7.0%	240	9.9%	844
≤6
7	1457	16.9%	492	20.3%	1949
8–10	6575	76.1%	1689	69.8%	8264
PSA value	4069	47.1%	903	37.3%	4972
<10
10–20	1688	19.5%	444	18.3%	2132
>20	2879	33.3%	1074	44.4%	3953
Number of unfavorable prognostic factors
1	6931	80.3%	1873	77.4%	8804
2	1490	17.3%	480	19.8%	1970
3	215	2.5%	68	2.8%	283
Age	69 395	13 4.6%	68 180	13 7.4%	69 575
Median (interquartile range)
<55
55–64	2125	24.6%	645	26.6%	2770
65–74	3584	41.5%	989	40.9%	4573
75+	2532	29.3%	607	25.1%	3139
Marital Status
Married or domestic partners	5729	66.3%	1531	63.2%	7260
Never married, divorced, widowed, separated	2135	24.7%	598	24.7%	1556
unknown	772	8.9%	292	12.1%	1064
Primary payer	304	3.5%	143	5.9%	447
No known insurance
Not insured/self-pay	84	1.0%	54	2.2%	138
Unknown	220	2.5%	89	3.7%	309
Insured	8332	96.5%	2278	94.1%	10610
Private	3750	43.4%	993	41.0%	4743
Public/Medicaid	358	4.1%	452	18.7%	810
Medicare	3770	43.7%	745	30.8%	4515
Veterans Affairs/ Military	454	5.3%	88	3.6%	542
Neighborhood SES tertile	1471	17.0%	1091	45.1%	2562
Lowest
Middle	2914	33.7%	843	34.8%	3757
Highest	4251	49.2%	487	20.1%	4738
Seen at NCI designated Cancer center	6810	78.9%	2085	86.1%	8895
No
Yes	1826	21.1%	336	13.9%	2162